Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Louis

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Journal of Neurosurgery|May 1, 1992
The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapyJ Glass, F H Hochberg, M L Gruber, et al.
Human Pathology|December 1, 1992
Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic studyD N Louis, A von Deimling, G R Dickersin, et al.
Cancer Research|January 1, 1996
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlatedK Ueki, Y Ono, J W Henson, et al.
The American Journal of Pathology|July 5, 2001
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosisH Sasaki, M C Zlatescu, R A Betensky, et al.
The American Journal of Surgical Pathology|September 8, 2000
Primary lymphoma of peripheral nerve: report of four casesJ Misdraji, Y Ino, D N Louis, et al.
Genes & Development|August 4, 2001
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoC Dai, J C Celestino, Y Okada, et al.
Leukemia|March 23, 1999
Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaM B Møller, Y Ino, A M Gerdes, et al.
American Journal of Clinical Pathology|June 1, 1995
Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host originD J Weissmann, J A Ferry, N L Harris, et al.
Neuropathology and Applied Neurobiology|December 21, 2000
Molecular genetics of radiographically defined de novo glioblastoma multiformeA Tortosa, Y Ino, N Odell, et al.
Clinical Endocrinology|January 13, 1998
Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumoursD C Chung, A P Smith, D N Louis, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Journal of Neurosurgery|May 1, 1992
The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapyJ Glass, F H Hochberg, M L Gruber, et al.
Human Pathology|December 1, 1992
Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic studyD N Louis, A von Deimling, G R Dickersin, et al.
Cancer Research|January 1, 1996
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlatedK Ueki, Y Ono, J W Henson, et al.
The American Journal of Pathology|July 5, 2001
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosisH Sasaki, M C Zlatescu, R A Betensky, et al.
The American Journal of Surgical Pathology|September 8, 2000
Primary lymphoma of peripheral nerve: report of four casesJ Misdraji, Y Ino, D N Louis, et al.
Genes & Development|August 4, 2001
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoC Dai, J C Celestino, Y Okada, et al.
Leukemia|March 23, 1999
Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaM B Møller, Y Ino, A M Gerdes, et al.
American Journal of Clinical Pathology|June 1, 1995
Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host originD J Weissmann, J A Ferry, N L Harris, et al.
Neuropathology and Applied Neurobiology|December 21, 2000
Molecular genetics of radiographically defined de novo glioblastoma multiformeA Tortosa, Y Ino, N Odell, et al.
Clinical Endocrinology|January 13, 1998
Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumoursD C Chung, A P Smith, D N Louis, et al.
Pageof 17